NCT03256916 2026-02-24
NELCER
Tata Memorial Hospital
Phase 3 Completed
Clinical Trials
11 trialsNCT01279135 2026-02-06
PARCER
Tata Memorial Hospital
Phase 3 Completed
NCT07164534 2026-02-04
CHOC-LATE
Tata Memorial Hospital
Phase 3 Not yet recruiting
NCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
NCT00193739 2019-09-20
NACTcervix
Tata Memorial Hospital
Phase 3 Unknown
NCT02957266 2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3 Unknown
NCT00193830 2015-05-06
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
Tata Memorial Hospital
Phase 3 Completed
NCT02083211 2015-04-14
Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
National Institute of Cancerología
Phase 3 Completed
NCT00122772 2011-10-14
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy
International Atomic Energy Agency
Phase 3 Completed
NCT00122746 2011-10-13
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
International Atomic Energy Agency
Phase 3 Unknown
NCT00532818 2009-03-30
Hydralazine Valproate for Cervical Cancer
National Institute of Cancerología
Phase 3 Unknown